Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Hypha Labs (FUNI) Other Accumulated Expenses (2023 - 2025)

Hypha Labs filings provide 3 years of Other Accumulated Expenses readings, the most recent being $27500.0 for Q3 2025.

  • On a quarterly basis, Other Accumulated Expenses rose 175.0% to $27500.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $27500.0, a 175.0% increase, with the full-year FY2025 number at $27500.0, up 175.0% from a year prior.
  • Other Accumulated Expenses hit $27500.0 in Q3 2025 for Hypha Labs, up from $10000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $138000.0 in Q3 2023 to a low of $5000.0 in Q2 2023.
  • Median Other Accumulated Expenses over the past 3 years was $20000.0 (2024), compared with a mean of $35062.5.
  • The widest YoY moves for Other Accumulated Expenses: up 300.0% in 2024, down 92.75% in 2024.
  • Hypha Labs' Other Accumulated Expenses stood at $15000.0 in 2023, then tumbled by 33.33% to $10000.0 in 2024, then surged by 175.0% to $27500.0 in 2025.
  • The last three reported values for Other Accumulated Expenses were $27500.0 (Q3 2025), $10000.0 (Q3 2024), and $20000.0 (Q2 2024) per Business Quant data.